10 Regenerative Medicine and Applications of Stem Cell Research June 1, 2010)
By: tawkaw OpenCourseWare
Read the rest here:
10 Regenerative Medicine and Applications of Stem Cell Research June 1, 2010) - Video
The application of stem cells in AD - Prof Eva Sykova
Neurobiologist do not have good markers for Alzheimer #39;s diseese which able early diagnosis. Thus, usually the AD patients have fully developed pathology in brain. Using stem cells scientists...
By: Bio-Tech Media
See the original post here:
The application of stem cells in AD - Prof Eva Sykova - Video
MIAMI (PRWEB) December 01, 2014
MIAMI, Dec. 1, 2014Stem Cell Training, Inc., a division of Global Stem Cells Group, Inc., has announced plans to launch a post graduate studies program in stem cell therapies and regenerative medicine in 2015.
The program will include five days of intensive, interactive training coursework with classroom instruction and laboratory practice through didactic lectures, hands-on practical experience in laboratory protocols and relevant lessons in regulatory practices. Global Stem Cells Group Advisory Board member Dr. David B. Harrell, PhD will teach the coursework and perform laboratory instruction, accompanied by a series of guest lecturers from the Global Stem Cells Group faculty of scientists.
Attendees will receive hands-on training in techniques for a variety of laboratory processes, and gain insight into the inner workings of a cGMP laboratory and FDA registered tissue bank. Regenerative medicine experts with more 15 years of experience in the field will train attendees and provide the necessary tools to implement regulatory and clinical guidelines in a cGMP laboratory setting
The graduate course is to be held four times in Miami in 2015.
Course details, objectives and instruction include:
Didactic Lectures will include:
For additional information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-224-1858.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Read the original here:
Global Stem Cell Groups Stem Cell Training to Launch Post-graduate Studies Program in Stem Cell Therapies and ...
Okayama City, Japan (PRWEB UK) 2 December 2014
Researchers at Okayama University Graduate School of Medicine and Kyorin University School of Medicine have successfully generated a kidney-like structure from just a single cell.
It has been predicted that the kidney will be among the last organs successfully regenerated in vitro due to its complex structure and multiple functions, states Shinji Kitamura, Hiroyuki Sakurai and Hirofumi Makino at the beginning of their latest report, before continuing to describe results suggesting a far more positive prognosis for the pace of kidney regeneration research. Despite the anatomical challenges posed by the kidney anatomy and the complexities understood from embryonic kidney development processes, the researchers have demonstrated that kidney-like structures can be generated from just a single adult kidney stem cell.
In embryos, kidney development requires two types of primordial cells cells at the earliest stage of development. However by generating kidney-like structures from a single type of kidney stem cell the researchers provide evidence for differences in the organ development in adults and embryos.
Kitamura, Sakurai and Makino researchers from Okayama and Kyorin Universities - took kidney stem cells from the different kidney components of microdissected adult rats and grew them in culture. A method for growing three-dimensional cell clusters showed that kidney-like structures could form so long as the initial cell cluster was large enough.
The minimum cluster size required might suggest that not all the kidney stem cells have stem cell characteristics. Therefore the researchers cloned kidney stem cells and confirmed that kidney-like structures still formed from the clusters of clone cells after a few weeks.
The researchers add, Although the physiological roles of such cells are currently unclear, analogous cells in the adult human kidney would be a valuable resource for the regeneration of kidneys in vitro.
Background Kidney structure There are more than a dozen distinct types of cell in the kidneys. The basic structural unit of the kidney is the nephron, which filters the blood to regulate the concentration of water and soluble substances such as sodium salts. Each nephron comprises several well-defined segments: the glomerulus, the proximal tubule, the loop of Henle, the distal tube and the collecting duct.
In embryo kidney organogenesis two primordial cell types are required to differentiate into all the different cell types in the kidney: metanephric mesenchymal cells and uteric bud cells. Kitamura, Sakurai and Makino produced kidney cells that could differentiate into a kidney-like structure without these primordial cell types, suggesting these are adult kidney stem cells.
Obtaining kidney stem cells The researchers microdissected adult rat kidneys into segments from the glomeruli, proximal convoluted tubule (S1/PCT), proximal straight tubule (S2, S3), medullary thick ascending limb of Henles loop and the collecting duct. They then grew the cells on mouse mesenchymal cells. While there is no known single biomarker for adult kidney stem cells, immunohistochemical anaylysis identified a number of markers in the kidney stem cells- that are found in embryonic or adult kidneys.
Follow this link:
Kidney organ regeneration research leaps forward
- As improved R&D climate supports development, stem cell therapeutics market expected to boom globally
KUALA LUMPUR, Malaysia, Dec. 2, 2014 /PRNewswire/ -- Stem cells have the potential to transform healthcare by enabling the cost-effective treatment of many conditions that currently have poor treatment options. This will be particularly important for the rapidly growing aged population as well as the rising proportion of patients with neurological and chronic conditions. Stem cells may enable regenerative treatments that avoid traditional drugs, devices and surgery for these patient groups.
New analysis from Frost & Sullivan, Analysis of the Global Stem Cell Market, finds that the market earned revenues of US$40.01 billion in 2013 and estimates this to nearly triple to US$117.66 billion in 2018 at a compound annual growth rate of 24.1 percent. The study covers human adult and embryonic stem cells. While North America is the market leader with more than half of the global stem cell market share, the Asia-Pacific is expected to record the highest compound annual growth rate (CAGR) during the forecast period. In fact, the APAC stem cell market, which was valued at US$5.60 billion in 2013, is projected to increase to US$18.71 billion by 2018.
For complimentary access to more information on this research, please visit: http://corpcom.frost.com/forms/APAC_PR_DJeremiah_P805-52_10Nov14.
"The overall R&D funding for stem cell research has increased significantly in the past 5 to 10 years and will reach desired heights in the years to come," said Frost & Sullivan Healthcare Consultant Sanjeev Kumar. "The number of venture capital firms investing in stem cell research has risen and government funding agencies have begun to acknowledge the future benefits of the stem cell industry."
While the stiff regulations that previously guarded stem cell research have begun to relax, other legal and ethical issues continue to hamper research. For instance, research institutes that adopt policies addressing concerns surrounding the use of human embryonic tissues may hinder the overall research process, which usually involves several collaborative enterprises. Other market challenges include insurers' reluctance to pay for expensive stem cell therapies and the likelihood that patients themselves will be unable to afford these treatments.
"The global stem cell industry is in an early stage of development, with a handful of small and large participants," noted Kumar. "In the near future, mergers, acquisitions and collaborations will accelerate growth, with multinational companies and larger pharmaceutical companies playing a key role in facilitating these activities. As the market evolves, standards and new regulatory frameworks are expected to ease market challenges."
In the meantime, the market's growth potential is being underlined by promising results from clinical trials and the escalating importance of stem cell banking services across the globe. Eventually, the technology is expected to play a crucial function in various areas including neurological disorders, orthopaedics, cancer, haematological disorders, injuries and wound care, cardiovascular diseases, spinal cord injuries, diabetes, incontinence and liver disorders. Therapeutics manufacturers are also likely to explore the relevance of stem cells in other areas and combine them with existing applications to enhance treatment options.
Analysis of the Global Stem Cell Market is part of the Life Sciences (http://www.lifesciences.frost.com) Growth Partnership Service program. Frost & Sullivan's related studies include: Analysis of the Global Infectious Disease Diagnostics Market, Western European Companion Diagnostics Market, Analysis of the Global Biosimilars Market, and Analysis of the US Retinal Therapeutics Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Here is the original post:
Stem Cells to Revolutionise the Future of Diagnostic and Therapeutic Medicine
MIAMI (PRWEB) December 01, 2014
GlobalStemCellsGroup.com has announced plans to team with Portal Medestetica, the largest physician portal in Lain America, to launch Portalstemcells.com, a new portal dedicated to providing physicians in Spain and Latin America with relevant information, clinical research news and products relating to stem cells and regenerative medicine.
The new collaboration between Global Stem Cells Group and Portal Medestetica will answer a growing need to expand the reach of high-impact news, studies and breakthroughs, and significantly advance the clinical utilization of stem cell research and clinical trials throughout Latin America. The Portalstemcells.com site is designed to help promote the latest state-of-the-art developments in regenerative medicine as they become available, and to share educational content with physicians throughout the region.
Portalstemcells.com will be the ideal vehicle to promote education and cutting-edge science throughout the region, says Ricardo de Cubas, founder of Global Stem Cells Group. The potential of regenerative medicine and stem cells therapies inspiring the medical community to find real opportunities to repair or replace tissue damaged from disease, relieve pain and provide the potential for curing chronic diseases where no cure existed before.
The Portalstemcells.com site is aimed at fostering growth and ethical development in the fast-moving field of stem cell medicine by filling a gap in the resources available throughout Latin America. The goal is to elevate the delivery of stem cell science in order to impact the lives of many patients worldwide.
For more information visit the Global Stem Cells website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Go here to see the original:
Global Stem Cells Group and Portal Medestetica to Launch Latin American Stem Cell Portal
Stem Cell Therapy Skin Repair, Anti Aging and Anti Wrinkle Cream - As Seen On Tv - Look Younger
http://www.ReadTheReviewsFirst.com Truvisage Anti-Aging Skin Care System Free Trial.
By: Greg Smith
See the original post here:
Stem Cell Therapy Skin Repair, Anti Aging and Anti Wrinkle Cream - As Seen On Tv - Look Younger - Video
TESTIMONI LAMININE - Ginjal Diabetes dan Komplikasi
Kunjungi website kami http://lamininestemcell.com Contacts: LIA MASTURA Phone: 081214804542 | WA: 088218497617 PIN BB: 7E97FF36 MIRA MASTURA Phone: 089657194720.
By: Laminine Nutrisi Stem Cell Terbaik
More:
TESTIMONI LAMININE - Ginjal Diabetes dan Komplikasi - Video
Stem Cell Therapy Skin Repair and Anti-Wrinkle Cream
http://www.ReadTheReviewsFirst.com Truvisage Anti-Aging Skin Care System Free Trial.
By: Greg Smith
Read more:
Stem Cell Therapy Skin Repair and Anti-Wrinkle Cream - Video
Latest Hair Loss Research : Stem Cell Therapy and Stem Cell Nutrition for Hair Loss
For More Details Like Us : https://www.facebook.com/SuperStemCellNutrition.
By: Palu Sot
View post:
Latest Hair Loss Research : Stem Cell Therapy and Stem Cell Nutrition for Hair Loss - Video
Q A Jeunesse LUMINESCE with Dr Nathan Newman TQnvZgn J2w
Dr. Nathan Newman answers questions how adult stem cells are revolutionizing medicine and how they #39;re already being used in treatment of cosmetic and reconstructive to rejuvenate damaged tissues ...
By: Credo
Visit link:
Q&A Jeunesse LUMINESCE with Dr Nathan Newman TQnvZgn J2w - Video
Stem Cell Therapy Project
Daniel, John, Magno, Thahn, Victor, Vivian show the world just exactly what stem cells really are.
By: John Peterman
Read the original:
Stem Cell Therapy Project - Video
Stem Cell Therapy - BioLogic Anti-Aging Skin Cream
http://www.ReadTheReviewsFirst.com Truvisage Anti-Aging Skin Care International Is Better Than Botox!
By: Greg Smith
Read more from the original source:
Stem Cell Therapy - BioLogic Anti-Aging Skin Cream - Video
Cell Therapy Limited on Crowdcube - Repairing Broken Hearts
HeartcelTM is a novel stem cell therapy that can regenerate the heart following heart failure - a Cell Therapy Ltd Medicine.
By: Cell Therapy Ltd
See the original post here:
Cell Therapy Limited on Crowdcube - Repairing Broken Hearts - Video
Stem Cell Therapy to Treat Equine Tendon Injuries
A brief explanation of tendon injuries and how stem cell therapy can be used to treat them.
By: Animal Science
More here:
Stem Cell Therapy to Treat Equine Tendon Injuries - Video
Stem cells transformed into heart tissue
In a breakthrough process, scientists are transforming stem cells into actual beating heart tissue. It could someday lead to new drug treatments for heart disease or even lab-created hearts...
By: CBSNews.com Web Extras
Read more here:
Stem cells transformed into heart tissue - Video
Stem Cells Repair All Body Organs
World #39;s First - Stem Cell Enhancer.
By: Dave W Easter
Go here to see the original:
Stem Cells Repair All Body Organs - Video
Genetically engineered stem cells to make and secrete toxins that kill brain cancer cells
Genetically engineered stem cells to make and secrete toxins that kill brain cancer cells. Subscribe this channel to watch more motivational, inspirational, valuable and informative videos...
By: Health Mind Body Spirit
Read more:
Genetically engineered stem cells to make and secrete toxins that kill brain cancer cells - Video
Global Cell Expansion Market Research Report 2019
New Market Research Report on Cell Expansion Market by Product (Reagent, Media, Serum, Bioreactors, Centrifuge), Cell Type (human, animal), Application (Stem Cell Research, Regenerative...
By: David clark
See the original post:
Global Cell Expansion Market Research Report 2019 - Video
Stem Cell Therapy Anti Aging Skin Cream Review and Exclusive Deal
http://www.ReadTheReviewsFirst.com Truvisage Anti-Aging Skin Care System Free Trial.
By: Greg Smith
Excerpt from:
Stem Cell Therapy Anti Aging Skin Cream Review and Exclusive Deal - Video